|
INBX Inhibrx Biosciences Inc 2007919 |
| Balance Sheet |
|
Current Assets
|
207,446,000 |
|
Assets
|
222,562,000 |
|
Current Liabilities
|
44,095,000 |
|
Liabilities
|
44,095,000 |
|
Equity
|
178,467,000 |
|
Shares Out
|
14,476,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-150,689,000 |
|
Investing Cash Flow
|
-2,581,000 |
| Market Analysis |
Market Cap
|
249,998,799 |
|
Price
|
13.49 |
|
BVPS
|
12.33 |
|
PB
|
1.09 |
|
EPS
|
121.21 |
|
PE
|
0.14 |
|
PS
|
1.46 |
|
FCF
|
-153,270,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INBX documents filed with the SEC.
INBX Filings
Clear
